Dr. Andrew Jackson, MD

NPI: 1760738355
Total Payments
$18,799
2024 Payments
$7,618
Companies
30
Transactions
163
Medicare Patients
6,023
Medicare Billing
$2.3M

Payment Breakdown by Category

Consulting$14,746 (78.4%)
Food & Beverage$2,885 (15.3%)
Travel$1,103 (5.9%)
Education$65.20 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $14,746 3 78.4%
Food and Beverage $2,885 150 15.3%
Travel and Lodging $1,103 3 5.9%
Education $65.20 7 0.3%

Top Paying Companies

Company Total Records Latest Year
Alexion Pharmaceuticals, Inc. $14,133 13 $0 (2024)
Genmab U.S., Inc. $2,159 3 $0 (2024)
PFIZER INC. $395.03 36 $0 (2018)
Novartis Pharmaceuticals Corporation $363.87 13 $0 (2024)
Celgene Corporation $260.03 15 $0 (2018)
E.R. Squibb & Sons, L.L.C. $170.23 9 $0 (2017)
Lilly USA, LLC $153.05 12 $0 (2018)
Straumann USA LLC $126.85 6 $0 (2020)
Eisai Inc. $120.60 6 $0 (2024)
Bayer HealthCare Pharmaceuticals Inc. $108.71 7 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,618 8 Alexion Pharmaceuticals, Inc. ($5,290)
2023 $8,712 6 Alexion Pharmaceuticals, Inc. ($8,712)
2022 $55.05 3 Sirtex Medical Inc ($25.39)
2020 $126.85 6 Straumann USA LLC ($126.85)
2018 $680.40 44 PFIZER INC. ($195.33)
2017 $1,606 96 PFIZER INC. ($199.70)

All Payment Transactions

163 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
10/26/2024 Genmab U.S., Inc. Epkinly (Drug) Consulting Fee Cash or cash equivalent $2,096.25 General
Category: Oncology
10/26/2024 Genmab U.S., Inc. Epkinly (Drug) Food and Beverage In-kind items and services $53.45 General
Category: Oncology
10/26/2024 Genmab U.S., Inc. Epkinly (Drug) Travel and Lodging Cash or cash equivalent $9.38 General
Category: Oncology
10/11/2024 SpringWorks Therapeutics, Inc. OGSIVEO (Drug) Food and Beverage In-kind items and services $19.27 General
Category: DESMOID TUMORS
09/04/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $110.81 General
Category: Oncology
05/30/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $24.85 General
Category: Oncology
04/25/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Consulting Fee Cash or cash equivalent $5,290.00 General
Category: Rare Disease
01/08/2024 ABBVIE INC. IMBRUVICA (Drug), EPKINLY Food and Beverage In-kind items and services $13.74 General
Category: ONCOLOGY
08/31/2023 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $7,360.00 General
08/11/2023 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $59.94 General
08/11/2023 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $49.83 General
08/10/2023 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $595.02 General
08/10/2023 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $498.11 General
08/10/2023 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $149.50 General
12/07/2022 Bayer HealthCare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $12.57 General
Category: Oncology
08/24/2022 Myriad Genetic Laboratories, Inc. myRisk (Device) Food and Beverage Cash or cash equivalent $17.09 General
Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis
06/07/2022 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $25.39 General
Category: Interventional Oncology
12/22/2020 Straumann USA LLC Food and Beverage Cash or cash equivalent $13.74 General
11/23/2020 Straumann USA LLC Food and Beverage Cash or cash equivalent $17.84 General
09/18/2020 Straumann USA LLC Food and Beverage Cash or cash equivalent $15.48 General
08/26/2020 Straumann USA LLC Food and Beverage Cash or cash equivalent $36.71 General
07/23/2020 Straumann USA LLC Food and Beverage Cash or cash equivalent $21.46 General
07/13/2020 Straumann USA LLC Food and Beverage Cash or cash equivalent $21.62 General
10/16/2018 Radius Health, Inc. Tymlos (Biological) Food and Beverage In-kind items and services $14.18 General
Category: Endocrinology
06/22/2018 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $15.42 General
Category: Hematology/Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 33 1,691 100,867 $2.4M $469,993
2022 41 1,626 116,423 $4.0M $756,303
2021 36 1,490 83,243 $3.6M $732,398
2020 36 1,216 68,482 $2.2M $315,617
Total Patients
6,023
Total Services
369,015
Medicare Billing
$2.3M
Procedure Codes
146

All Medicare Procedures & Services

146 procedure records from CMS Medicare Utilization — Page 1 of 6

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J9271 Injection, pembrolizumab, 1 mg Office 2023 15 7,000 $955,000 $301,391 31.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 256 684 $251,712 $61,891 24.6%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 71 232 $164,024 $21,907 13.4%
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Office 2023 49 43,350 $216,750 $17,112 7.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 113 113 $63,845 $13,304 20.8%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2023 271 998 $35,928 $7,590 21.1%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 78 144 $45,072 $6,714 14.9%
80053 Blood test, comprehensive group of blood chemicals Office 2023 95 438 $28,032 $4,527 16.1%
96417 Administration of additional new drug or substance into vein, 1 hour or less Office 2023 29 90 $30,960 $4,314 13.9%
85055 Reticulated (young) platelet measurement Office 2023 35 111 $15,873 $3,888 24.5%
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less Office 2023 46 157 $24,649 $3,359 13.6%
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram Office 2023 15 21,600 $43,200 $3,353 7.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 47 53 $13,250 $3,164 23.9%
36415 Insertion of needle into vein for collection of blood sample Office 2023 119 357 $7,140 $2,999 42.0%
96375 Injection of additional new drug or substance into vein Office 2023 50 229 $24,732 $2,626 10.6%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 25 115 $18,515 $2,412 13.0%
96372 Injection of drug or substance under skin or into muscle Office 2023 41 153 $14,688 $1,529 10.4%
96360 Infusion into a vein for hydration, 31-60 minutes Office 2023 22 56 $14,336 $1,332 9.3%
J9267 Injection, paclitaxel, 1 mg Office 2023 14 12,906 $103,248 $1,305 1.3%
J1453 Injection, fosaprepitant, 1 mg Office 2023 27 9,150 $45,750 $1,026 2.2%
J9045 Injection, carboplatin, 50 mg Office 2023 17 425 $127,500 $839.34 0.7%
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test Office 2023 22 95 $3,230 $602.30 18.6%
96523 Irrigation of implanted venous access drug delivery device Office 2023 17 34 $3,876 $594.89 15.3%
J3489 Injection, zoledronic acid, 1 mg Office 2023 15 84 $36,204 $553.89 1.5%
J2469 Injection, palonosetron hcl, 25 mcg Office 2023 32 680 $77,520 $497.77 0.6%

About Dr. Andrew Jackson, MD

Dr. Andrew Jackson, MD is a Internal Medicine healthcare provider based in Shenandoah, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1760738355.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Jackson, MD has received a total of $18,799 in payments from pharmaceutical and medical device companies, with $7,618 received in 2024. These payments were reported across 163 transactions from 30 companies. The most common payment nature is "Consulting Fee" ($14,746).

As a Medicare-enrolled provider, Jackson has provided services to 6,023 Medicare beneficiaries, totaling 369,015 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 146 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Medical Oncology, Student in an Organized Health Care Education/Training Program
  • Location Shenandoah, TX
  • Active Since 08/01/2012
  • Last Updated 10/04/2023
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1760738355

Products in Payments

  • ULTOMIRIS (Biological) $5,290
  • Epkinly (Drug) $2,159
  • Abraxane (Drug) $145.43
  • AFINITOR (Drug) $140.60
  • SOLIRIS (Drug) $130.42
  • OPDIVO (Biological) $114.70
  • IBRANCE (Drug) $111.82
  • SCEMBLIX (Drug) $110.81
  • SUTENT (Drug) $99.41
  • ERBITUX (Drug) $89.00
  • CHANTIX (Drug) $86.30
  • Lenvima (Drug) $78.96
  • Neulasta (Biological) $71.27
  • SPRYCEL (Drug) $68.75
  • Xofigo (Drug) $62.76
  • IMFINZI (Drug) $61.11
  • Pomalyst (Drug) $59.56
  • Revlimid (Drug) $55.04
  • Somatuline Depot 120mg-.5ml (Drug) $49.69
  • JAKAFI (Drug) $49.65

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Shenandoah